comparemela.com
Home
Live Updates
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q4 2022 Earnings Call Transcript : comparemela.com
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode.
Related Keywords
United States
,
American
,
Vincent Anzalone
,
Patrick Obrien
,
Maury Raycroft
,
Christopher Anzalone
,
Ken Myszkowski
,
Tracie Oliver
,
James Hamilton
,
Chris Anzalone
,
Amgen
,
American Heart Association
,
Arrowhead Pharmaceuticals Inc
,
American Heart Association Scientific Sessions
,
Nasdaq
,
Arrowhead Pharmaceuticals Conference Call
,
Biggest Duty Free Companies
,
Semiconductor Manufacturing Countries
,
Securities Exchange
,
Arrowhead Pharmaceuticals
,
Call Transcript November
,
Arrowhead Pharmaceuticals Conference
,
Vice President
,
Investor Relations
,
Javier San Martin
,
Chief Medical Officer
,
Senior Vice President
,
Translational Medicine
,
Chief Financial Officer
,
Chief Commercial Officer
,
Patricko Brien
,
Chief Operating Officer
,
General Counsel
,
Shortage Countries
,
Securities Act
,
Securities Exchange Act
,
Javier San
,
Manufacturing Countries
,
Duty Free Companies
,
San Martin
,
New England Journal
,
Royalty Pharma
,
Royalty Purchase Agreement
,
Royalty Pharma Agreement
,
Interim Phase
,
Luca Issi
,
comparemela.com © 2020. All Rights Reserved.